Hedge Fund - Courage Capital
Coherus Biosciences Inc. (CHRS) Bond
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2024 - Q2 (2024-06-30) | $5,513,000 | 13.91% | 7,500,000 | $2.01 |
2 | 2024 - Q1 (2024-03-31) | $4,821,000 | 13.96% | 7,500,000 | $2.46 |
3 | 2023 - Q4 (2023-12-31) | $4,254,000 | 17.17% | 7,500,000 | $2.68 |
4 | 2023 - Q3 (2023-09-30) | $11,025,000 | 37.39% | 18,000,000 | $4.62 |
5 | 2023 - Q2 (2023-06-30) | $11,205,000 | 30.75% | 18,000,000 | $5.90 |
6 | 2023 - Q1 (2023-03-31) | $12,708,000 | 30.46% | 18,000,000 | $7.76 |
7 | 2022 - Q4 (2022-12-31) | $11,835,000 | 33.24% | 18,000,000 | $7.69 |
8 | 2022 - Q3 (2022-09-30) | $14,063,000 | 30.45% | 18,000,000 | $10.12 |
9 | 2022 - Q2 (2022-06-30) | $11,736,000 | 19.29% | 18,000,000 | $8.70 |
10 | 2022 - Q1 (2022-03-31) | $39,394,000 | 37.59% | 39,700,000 | $12.72 |
11 | 2021 - Q4 (2021-12-31) | $44,025,000 | 29.07% | 40,000,000 | $17.49 |
12 | 2021 - Q3 (2021-09-30) | $44,374,000 | 23.76% | 40,000,000 | $14.66 |
13 | 2021 - Q2 (2021-06-30) | $40,883,000 | 24.43% | 40,000,000 | $14.16 |
The displayed share prices are average quarterly stock market prices.